Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Mar 17;110(4):1023-1036.
doi: 10.1210/clinem/dgae666.

Comprehensive Study on Central Precocious Puberty: Molecular and Clinical Analyses in 90 Patients

Hiromune Narusawa  1   2 , Tomoe Ogawa  1 , Hideaki Yagasaki  2 , Keisuke Nagasaki  3 , Tatsuki Urakawa  1 , Tomohiro Saito  4 , Shun Soneda  5   6 , Saori Kinjo  7 , Shinichiro Sano  8 , Mitsukazu Mamada  9 , Shintaro Terashita  10 , Sumito Dateki  11 , Satoshi Narumi  1 , Yasuhiro Naiki  12 , Reiko Horikawa  12 , Tsutomu Ogata  13   14 , Maki Fukami  1 , Masayo Kagami  1
Affiliations

Comprehensive Study on Central Precocious Puberty: Molecular and Clinical Analyses in 90 Patients

Hiromune Narusawa et al. J Clin Endocrinol Metab. .

Abstract

Context: Defects in MKRN3, DLK1, KISS1, and KISS1R and some disorders, such as Temple syndrome (TS14), cause central precocious puberty (CPP). Recently, pathogenic variants (PVs) in MECP2 have been reported to be associated with CPP.

Objective: We aimed to clarify the contribution of (epi)genetic abnormalities to CPP and clinical and hormonal features in each etiology.

Methods: We conducted targeted sequencing for MKRN3, DLK1, MECP2, KISS1, and KISS1R and methylation analysis for screening of imprinting disorders such as TS14 associated with CPP in 90 patients with CPP (no history of brain injuries and negative brain magnetic resonance imaging) and collected their clinical and laboratory data. We measured serum DLK1 levels in 3 patients with TS14 and serum MKRN3 levels in 2 patients with MKRN3 genetic defects, together with some etiology-unknown patients with CPP and controls.

Results: We detected 8 patients with TS14 (6, epimutation; 1, mosaic maternal uniparental disomy chromosome 14; 1, microdeletion) and 3 patients with MKRN3 genetic defects (1, PV; 1, 13-bp deletion in the 5'-untranslated region [5'-UTR]; 1, microdeletion) with family histories of paternal early puberty. There were no patients with PVs identified in MECP2, KISS1, or KISS1R. We confirmed low serum MKRN3 level in the patient with a deletion in 5'-UTR. The median height at initial evaluation of TS14 patients was lower than that of all patients. Six patients with TS14 were born small for gestational age (SGA).

Conclusion: (Epi)genetic causes were identified in 12.2% of patients with CPP at our center. For patients with CPP born SGA or together with family histories of paternal early puberty, (epi)genetic testing for TS14 and MKRN3 genetic defects should be considered.

Keywords: MECP2; MKRN3; central precocious puberty; imprinted genes; imprinting disorders; temple syndrome.

PubMed Disclaimer

Comment in